Literature DB >> 11780597

Clinical management of psychiatric disorders in patients with HIV disease.

Eugene W Farber1, J Stephen McDaniel.   

Abstract

HIV disease presents considerable challenges that can affect adjustment and health-related behaviors. This article provides an overview of clinical considerations in the treatment of comorbid psychiatric disorders and problems in adjustment in HIV patients. First, the research literature is reviewed with respect to biomedical, intrapersonal, and psychosocial factors associated with HIV-related psychological adjustment and psychiatric complications. Next, a brief description is presented regarding prevalence and types of co-occurring psychiatric disorders seen in HIV patients. The article concludes with a discussion of clinical assessment and treatment considerations for psychiatric clinicians who work with HIV patients.

Entities:  

Mesh：

Year:  2002        PMID： 11780597     DOI： 10.1023/a:1012836516826

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN： 0033-2720


  24 in total

1.  Meta-analysis of the relationship between HIV infection and risk for depressive disorders.

Authors:  J A Ciesla; J E Roberts
Journal:  Am J Psychiatry       Date:  2001-05       Impact factor: 18.112

2.  Subjective HIV attribution theories, coping and psychological functioning among homosexual men with HIV.

Authors:  U Clement; L N Schönnesson
Journal:  AIDS Care       Date:  1998-06

3.  Cognitive processing, discovery of meaning, CD4 decline, and AIDS-related mortality among bereaved HIV-seropositive men.

Authors:  J E Bower; M E Kemeny; S E Taylor; J L Fahey
Journal:  J Consult Clin Psychol       Date:  1998-12

4.  Longitudinal development of distress, coping and quality of life in HIV-positive persons.

Authors:  P Leiberich; M Engeter; E Olbrich; A Rubbert; K Schumacher; M Brieger; J R Kalden; P Joraschky
Journal:  Psychother Psychosom       Date:  1997       Impact factor: 17.659

5.  Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men.

Authors:  S K Lutgendorf; M H Antoni; G Ironson; K Starr; N Costello; M Zuckerman; N Klimas; M A Fletcher; N Schneiderman
Journal:  Psychosom Med       Date:  1998 Mar-Apr       Impact factor: 4.312

6.  Psychological effects of HAART: a 2-year study.

Authors:  J G Rabkin; S J Ferrando; S H Lin; M Sewell; M McElhiney
Journal:  Psychosom Med       Date:  2000 May-Jun       Impact factor: 4.312

7.  Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men. A 2-year follow-up study.

Authors:  J Leserman; J M Petitto; D O Perkins; J D Folds; R N Golden; D L Evans
Journal:  Arch Gen Psychiatry       Date:  1997-03

8.  Axis I psychiatric symptoms associated with HIV infection and personality disorder.

Authors:  J G Johnson; J B Williams; J G Rabkin; R R Goetz; R H Remien
Journal:  Am J Psychiatry       Date:  1995-04       Impact factor: 18.112

9.  Somatic symptoms and HIV infection: relationship to depressive symptoms and indicators of HIV disease.

Authors:  D O Perkins; J Leserman; R A Stern; S F Baum; D Liao; R N Golden; D L Evans
Journal:  Am J Psychiatry       Date:  1995-12       Impact factor: 18.112

10.  Emotional distress, coping, and adjustment in human immunodeficiency virus infection and acquired immune deficiency syndrome.

Authors:  R Krikorian; J Kay; W M Liang
Journal:  J Nerv Ment Dis       Date:  1995-05       Impact factor: 2.254
View more
  2 in total

1.  A randomized controlled trial of mindfulness-based stress reduction to manage affective symptoms and improve quality of life in gay men living with HIV.

Authors:  Bill Gayner; Mary Jane Esplen; Peter DeRoche; Jiahui Wong; Scott Bishop; Lynn Kavanagh; Kate Butler
Journal:  J Behav Med       Date:  2011-05-20

Review 2.  HIV and depression: 2008 review and update.

Authors:  Judith G Rabkin
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.